Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Warts × Nitric Oxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

resiquimod 5 human papillomavirus vaccine, L1 type 16, 18 1 VP-102 1 Sugars 1 PRA1 protein, Candida albicans 1 Nitric Oxide 1 Maltose 1 Interferon-alpha 1 Cholecalciferol 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05877313 2024-04-17

Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Sanotize Research and Development corp.

Phase 2 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡